Indivior Pharmaceuticals (INDV) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to $200.0 million.
- Indivior Pharmaceuticals' Other Gross PP&E Adjustments rose 61282.05% to $200.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $200.0 million, marking a year-over-year increase of 61282.05%. This contributed to the annual value of $144.0 million for FY2024, which is 2100.84% up from last year.
- Latest data reveals that Indivior Pharmaceuticals reported Other Gross PP&E Adjustments of $200.0 million as of Q3 2025, which was up 61282.05% from $175.0 million recorded in Q2 2025.
- In the past 5 years, Indivior Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $200.0 million during Q3 2025, and its lowest value of -$39.0 million during Q3 2024.
- Its 4-year average for Other Gross PP&E Adjustments is $54.0 million, with a median of -$31.0 million in 2022.
- In the last 5 years, Indivior Pharmaceuticals' Other Gross PP&E Adjustments crashed by 2187.5% in 2024 and then soared by 61470.59% in 2025.
- Quarter analysis of 4 years shows Indivior Pharmaceuticals' Other Gross PP&E Adjustments stood at -$31.0 million in 2022, then skyrocketed by 483.87% to $119.0 million in 2023, then grew by 21.01% to $144.0 million in 2024, then soared by 38.89% to $200.0 million in 2025.
- Its Other Gross PP&E Adjustments stands at $200.0 million for Q3 2025, versus $175.0 million for Q2 2025 and $160.0 million for Q1 2025.